ClinicalTrials.gg
RecruitingNCT06576284Updated Nov 20, 2024

A 36-month Analysis of the Clinical Performance of Individualized CAD/CAM-produced Dental Implants: a Cohort Study

An observational study in Tooth Loss and Dental Implant, sponsored by University of Sao Paulo. Recruiting at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2024-11-20.

Sponsored by University of Sao Paulo · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year 1 month ago, but the record still lists the study as recruiting.
  • Started Oct 2024; still recruiting 2 years 1 month later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
12
Sex
All
01

Study summary

The goal of this prospective cohort study is to evaluate the clinical performance of a new generation of customized CAD/CAM pre-fabricated root-analog dental implants over a 36-month period. The main questions it aims to answer are:

  1. Are these novel implants safe, effective, and clinically viable for 36 months?
  2. Do these drilling-free implants result in better post-operative outcomes compared to traditional implant techniques? Twelve patients receiving these customized implants immediately after tooth extraction will undergo clinical and radiographic examinations at 12, 24, and 36 months after prosthesis installation. The study will assess peri-implant tissue health, post-operative comfort, bone preservation, tissue integration, and implant survival rates.
02

Conditions studied

  • Tooth Loss
  • Dental Implant

Browse trials for

03

In context

Tooth Loss

165 studies on the registry are indexed under Tooth Loss; 44 are open to participants now.

This study's planned enrollment of 12 is below the median of 80 across 40 observational studies indexed under Tooth Loss.

Browse Tooth Loss studies →

Lead sponsor

University of Sao Paulo is the lead sponsor of 1,035 studies on the registry; 95 are open to participants now.

Of its 8 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Individuals who received a personalized dental implant using the iDENTICAL Dental Implant System

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Received a personalized dental implant using the iDENTICAL Dental Implant System during the previous interventional phase;
  • Completed the 12-month follow-up period after implant placement in the previous interventional phase;
  • Available for follow-up evaluations during the 36 months of the observational study.

Exclusion criteria

Exclusion Criteria:

  • Occurrence of serious complications (implant loss, infection, etc.) during the previous interventional phase;
  • Development of uncontrolled medical conditions during the follow-up period;
  • Inability to attend scheduled follow-up visits;
  • Refusal to participate in the observational study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
12 participants (estimated)
Target follow-up
36 Months
Patient registry
Yes

Groups and cohorts

  • Personalized implant

    This is an observational, prospective, single-cohort study conducted at the University of São Paulo, São Paulo, Brazil, involving individuals who received a personalized dental implant using the iDENTICAL Dental Implant System. The aim is to evaluate the safety, efficacy, and clinical viability of these customized implants over a 36-month follow-up period.

06

What researchers measure

Primary outcomes

  1. Radiographic success

    Radiographic success, defined as the absence of peri-implant radiolucency and lack of progressive loss (\> 1.7 mm) of marginal bone level (MBL) over the 36 months following implant restoration.

    Time frame: 12 months, 24 months and 36 months

Secondary outcomes

  1. Linear horizontal changes of peri-implant soft tissues

    measured from intraoral scans at 1mm, 3mm, and 5mm below the reference gingival margin level at the time of crown placement, at 12, 24, and 36 months.

    Time frame: 12 months, 24 months and 36 months

  2. Prosthetic Level outomes

    Chipping/fracture of material; Loss of retention of restoration (cementation cement fracture); Connector (Abutment) fracture; Loss/failure of restoration substrate requiring new restoration; The restoration functions as intended/satisfactorily for the subject

    Time frame: 12 months, 24 months and 36 months

  3. Peri-implant clinical parameters

    Mobility (MOB)

    Time frame: 12 months, 24 months and 36 months

07

Study locations

1 of 1 sites recruiting
  • School of Dentistry - University of São Paulo
    São Paulo, 05508-900, Brazil
    Recruiting
    • Giuseppe A Romito, PhD · Contactgaromito@usp.br · +55 11 30917833
    • Marilia Gomes · Contactmaricg@usp.br · +55 11 30917833
    • Giuseppe A Romito, PhD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2024 (actual). Primary completion is estimated for Oct 2025, 12 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 19, 2024
First posted
Aug 28, 2024
StartActual
Oct 2, 2024
Primary completionEst.
Oct 2025
CompletionEst.
Oct 2026
Last update
Nov 20, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 20, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06576284
Responsible party
Giuseppe Alexandre Romito (Vice Dean, University of Sao Paulo) — Principal investigator
First posted
Aug 28, 2024
Start date
Oct 2, 2024
Primary completion
Oct 2025 (estimated)
Completion
Oct 2026 (estimated)
Last update
Nov 20, 2024

Study contacts

Romito
Contact
garomito@usp.br
(11) 992051939 ext. +55
Cristina C Villar
Contact
villar@usp.br
(11)968403872 ext. +55
Giuseppe A Romito, PhD
principal investigator · University of Sao Paulo

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion